HEALTH AND SAFETY

» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing

 

More Information on Device Promotion

Letter to the FDA Regarding the Apparent Illegal Marketing and Promotion of the LipoTron Medical Device

July 18, 2012

View letter as PDF.

View attachments as a PDF.

View our press release.

For several years, the Food and Drug Administration (FDA) has been aware of the apparent illegal distribution, sale, and promotion of the LipoTron medical device without the approval or clearance of the FDA. Public Citizen obtained documents from a whistleblower that indicate that the apparently illegal marketing and promotion of this potentially dangerous device was brought to the attention of the FDA’s Office of Criminal Investigations more than two and a half years ago, but the FDA has failed to take action against the manufacturer and other entities involved in the distribution, sale, and promotion of the device, which is now being widely used throughout the U.S.

July 23, 2012 Follow-Up Letter to FDA Regarding LipoTron Device

August 3, 2012 letter from an attorney representing Advanced Aesthetic Concepts (AAC) — the distributor of the LipoTron device — demanding that Public Citizen cease and desist all communications about AAC’s activities involving the marketing and promotion of the LipoTron device and threatening to file a lawsuit against Public Citizen unless it complied with this demand. (PDF)

August 22, 2012 letter from Public Citizen rejecting the demand from AAC’s attorney. (PDF)

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.